Update: NCCN prostate cancer clinical practice guidelines Journal Article


Author: Scardino, P.
Article Title: Update: NCCN prostate cancer clinical practice guidelines
Abstract: Prostate cancer is the most common cancer in American men. This discussion focuses on recent updates to the NCCN guidelines, including new therapies and directions for future research. © Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; aged; middle aged; cancer surgery; prednisone; clinical trial; cancer recurrence; placebo; cancer growth; cancer risk; united states; conference paper; chemotherapy; cancer staging; antineoplastic agent; cancer grading; clinical practice; prostate specific antigen; cancer prevention; chemoprophylaxis; antineoplastic agents, phytogenic; mass screening; nccn clinical practice guidelines; practice guideline; cancer research; risk assessment; docetaxel; prostate cancer; prostate-specific antigen; prostatic neoplasms; prostatectomy; prostate tumor; prostate biopsy; mitoxantrone; finasteride; medical society; taxoids; hormonal therapy; taxoid; digital rectal examination; practice guidelines; estramustine
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 3
Issue: Suppl. 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2005-11-01
Start Page: S
End Page: 29
Language: English
PUBMED: 16280109
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 55" - "Export Date: 24 October 2012" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Peter T Scardino
    671 Scardino